search for


Current Status of Oncology Pharmacy Service and Role of Certified Oncology Pharmacists in Korean Hospitals
J. Kor. Soc. Health-syst. Pharm. 2019;36:498-517
Published online November 30, 2019;
© 2019 Korean Society of Health-System Pharmacists

Ae Ryoung Parka, Jin Young Moonb, Jung Ae Seob, Jong Hee Koc, Yoon Sun Reec, Ju Hyang Cheond, So Yeon Honge, Jung hyun Leef and Kyung im Kimf,†

Department of Pharmacy, Seoul St. Mary’s Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Koreaa
Department of Pharmacy, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si Gyeonggi-do, 10408, Republic of Koreab
Department of Pharmacy, Severance Hospital, Yonsei University Health System, 50-1 Yonsei-ro, Seodamun-gu, Seoul, 03722, Republic of Koreac
Department of Pharmacy, Yeungnam University Hospital, 170, Hyeonchung-ro, Nam-gu, Daegu, Republic of Koread
Department of Pharmacy, Seoul National University Bundang Hospital, Gumi-ro 173, gil 82, Bundang-gu, Seongnamcity, Gyeonggi-do, 13620, Republic of Koreae
College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong, 30019, Republic of Koreaf
Correspondence to: 김경임 Tel:044-860-1624
Received September 5, 2019; Revised October 2, 2019; Accepted October 4, 2019.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background : The Korean Society of Health-System Pharmacists conducted the first certified oncology pharmacist examination in 2010. Currently, there are more than 180 certified oncology pharmacists in Korea. The purpose of this study was to investigate the current status of oncology pharmacy service and the role of pharmacists and suggest future paths for certified oncology pharmacists in Korea.
Methods : The survey was conducted on pharmacists working at oncology pharmacies, as well as doctors and nurses with oncology pharmacy services experience. Additionally, the focus group interview was conducted with certified oncology pharmacists to evaluate pharmacists’needs regarding improving the certified pharmacist system.
Results : The survey was completed by 99 pharmacists, 33 doctors, and 65 nurses in 33 hospitals. Among the certified oncology pharmacists currently working, the percentage of those who work specifically in oncology pharmacies was 24.9%. Oncology pharmacy services comprise prescription review and intervention, medication history management, attending round and conference, education, quality improvement activity and research activity. When asked about the services provided by oncology pharmacists, the medical staff responded with prescription review and intervention, providing drug information, patient education, therapeutic drug monitoring consulting, adverse drug reaction monitoring, and medication history management. And the medical staff showed more than average satisfaction in each service field. In the focus group interview, similar findings were confirmed. Meanwhile, dissatisfactory factors included the combination of clinical and dispensing tasks, discontinuity of work due to department circulation, and difficulties caused by lack of manpower.
Conclusions : The results show that certified oncology pharmacists were performing more advanced services than general pharmacists. Also, the medical staffs were fully aware of the oncology pharmacy services and satisfied with such services. However, the current certified pharmacist system has a limitation in that it lacks laws as well as a compensation system.
Keywords : Oncology, Pharmacy service, Certified, Pharmacist

November 2019, 36 (4)